Toprak, KenanKaplangöray, MustafaMemioğlu, Tolgaİnanır, Mehmet2023-07-242023-07-242023Toprak, K., Kaplangöray, M., Memioglu, T., & İnanir, M. (2023). Is the predictive value of systemic immune-inflammation index superior to traditional markers in ST-elevation myocardial infarction patients?. Coronary Artery Disease, 34(4), 281-281.0954-69281473-5830http://dx.doi.org/10.1097/MCA.0000000000001238https://hdl.handle.net/20.500.12491/11348We read with great interest the recently published article ‘Systemic immune-inflammation index predicts in-hospital and long-term outcomes in patients with ST-segment elevation myocardial infarction’ by Öcal et al [1]. In their valuable, well designed, and presented research, the authors argue that the systemic immune-inflammation index (SII) is superior to traditional markers such as neutrophil-to-lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) in predicting in-hospital adverse events in patients with ST-elevation myocardial infarction (STEMI) and they also claim that the discriminative value of SII in predicting in-hospital mortality in STEMI patients is higher than NLR; however, when the whole article is evaluated, we think that some methodological and literary issues should be reviewed by the authors.eninfo:eu-repo/semantics/closedAccessST-elevation Myocardial Infarction (STEMI)NLRPLRLetter10.1097/MCA.0000000000001238344281281371022312-s2.0-85153904822Q3WOS:000979476100007Q3